History Questions for CBD Stricture on MRI
When evaluating a patient with CBD stricture on MRI, your history must systematically distinguish between malignant and benign etiologies while identifying specific risk factors for cholangiocarcinoma and other biliary pathology.
Essential Symptom Assessment
Cholestatic Symptoms
- Jaundice: Duration, progression (gradual vs. rapid), and severity 1, 2
- Pruritus: Presence and intensity
- Dark urine and pale/clay-colored stools: Timing and progression
- Abdominal pain or discomfort: Location, character, and relationship to eating 1
Constitutional Symptoms
- Weight loss: Amount and timeframe—significant unintentional weight loss suggests malignancy 1, 3
- Anorexia: Duration and severity 1
- Fever or chills: Suggests cholangitis or infectious etiology
Critical Risk Factor Assessment
Malignancy Risk Factors
Primary Sclerosing Cholangitis (PSC): This is the single most important risk factor for cholangiocarcinoma—ask specifically about:
- History of inflammatory bowel disease (ulcerative colitis or Crohn's disease)
- Prior diagnosis of PSC or abnormal liver enzymes 1
Choledochal Cysts: History of congenital biliary abnormalities or prior cyst resection—these patients require lifelong surveillance 1
Liver Fluke Exposure: Travel to or residence in endemic areas (Southeast Asia, particularly Thailand, Laos, Vietnam)—ask about consumption of raw or undercooked freshwater fish 1
Benign Stricture Causes
Chronic Pancreatitis:
- Alcohol consumption history (quantity, duration, pattern) 4
- Recurrent episodes of pancreatitis
- Chronic abdominal pain radiating to back 4
IgG4-Related Disease:
- History of autoimmune pancreatitis
- Other organ involvement (salivary glands, retroperitoneal fibrosis, kidney disease) 2
Infectious/Inflammatory:
- Recent biliary infections or cholangitis episodes
- History of tuberculosis or sarcoidosis 3
- Recurrent cholecystitis 5
Iatrogenic:
- Prior cholecystectomy or hepatobiliary surgery 6
- Prior ERCP with instrumentation
- History of biliary stenting 6
Ischemic:
- Liver transplantation history
- Hepatic artery thrombosis or stenosis
- Recent major cardiovascular events
Medication and Exposure History
- Immunosuppressive medications: May suggest underlying autoimmune condition
- Chemotherapy exposure: Can cause biliary sclerosis
- Radiation therapy: To upper abdomen or liver
Prior Diagnostic Workup
- Previous imaging studies and their findings
- Prior ERCP, EUS, or cholangioscopy results 2
- Previous biliary brushings or biopsies and their results 2
Timing and Progression
Duration of symptoms: Benign strictures in young patients often present with shorter symptom duration (weeks to months), while malignant strictures may have more insidious onset 5, 3
Key Clinical Pitfalls
The absence of jaundice does NOT exclude significant biliary pathology—alkaline phosphatase elevation may be the only biochemical indicator of cholestasis in chronic pancreatitis-related strictures 4. Additionally, CA19-9 levels must be interpreted cautiously as they can be falsely elevated in any biliary obstruction, not just malignancy 1. Young age does not exclude malignancy, particularly in patients with PSC or choledochal cysts 1, 5.
The presence of both CBD and intrahepatic bile duct dilation on imaging significantly increases the likelihood of finding causative pathology and should prompt more aggressive investigation 7.